{"id":12109,"date":"2019-09-04T18:02:49","date_gmt":"2019-09-04T18:02:49","guid":{"rendered":"https:\/\/iach2019.cme-congresses.com\/?page_id=12109"},"modified":"2019-09-04T18:39:33","modified_gmt":"2019-09-04T18:39:33","slug":"jazz-symposium","status":"publish","type":"page","link":"https:\/\/iach2019.cme-congresses.com\/jazz-symposium\/","title":{"rendered":"Jazz Symposium"},"content":{"rendered":"

\n\t\t\t\t\t
\n\t\t\t\t\t\t

Jazz Symposium<\/h2><\/div>
<\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div>
\n\t\t\t\t\t
\n\t\t\t\t\t\t
\"\"<\/span><\/div>
<\/div>
<\/div>

Jazz supported Industry Lunch Symposium (Hall A)
\nFriday, September 20th
\n10:45-12:15<\/span><\/em><\/p><\/h2><\/div>

<\/div>
<\/div>

Driving a change in outcomes for high-risk AML* and hepatic veno-occlusive disease<\/span>
\nChair: Dr Rafael Duarte<\/strong>, Spain<\/span><\/p><\/h2><\/div>

<\/div>
<\/div>\n
\n\n\n\n\n\n\n\n\n\n
10:45<\/td>\nWelcome and introduction
\nDr Rafael Duarte<\/strong>, Spain<\/td>\n<\/tr>\n
10:50<\/td>\nDriving change in outcomes for high-risk AML*
\n*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)<\/em>
\nProf. Thomas Cluzeau<\/strong>, France<\/td>\n<\/tr>\n
11:10<\/td>\nQ&A<\/td>\n<\/tr>\n
11:20<\/td>\nSurviving severe hepatic VOD: real-world evidence and new data
\nDr Rafael Duarte<\/strong>,\u00a0Spain<\/td>\n<\/tr>\n
11:40<\/td>\nBest practice in action in severe hepatic VOD
\nProf. Jos\u00e9 P\u00e9rez-Sim\u00f3n<\/strong>, Spain<\/td>\n<\/tr>\n
12:00<\/td>\nQ&A<\/td>\n<\/tr>\n
12:10<\/td>\nSummary and close
\nDr Rafael Duarte<\/strong>, Spain<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
<\/div>
<\/div>

This symposium is funded and organised by Jazz Pharmaceuticals.
\nThis symposium will contain promotional content and prescribing information will be available upon request and at the Jazz Pharmaceuticals exhibition stand.<\/p>\n<\/div>

<\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div>
\n\t\t\t\t\t
\n\t\t\t\t\t\t

Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse events via their national reporting system.
\nIn the United Kingdom: Reporting forms and information can be found at https:\/\/yellowcard.mhra.gov.uk\/<\/a>
\nAdverse events should also be reported to Jazz Pharmaceuticals at
\nAEreporting@jazzpharma.com<\/a> or by fax to +44 (0) 1865 598765<\/p>\n<\/div>

<\/div>\n\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"yst_prominent_words":[487,477,471,479,472,469,476,482,480,271,270,478,473,483,475,470,481,474,50,441],"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12109"}],"collection":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/comments?post=12109"}],"version-history":[{"count":0,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/pages\/12109\/revisions"}],"wp:attachment":[{"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/media?parent=12109"}],"wp:term":[{"taxonomy":"yst_prominent_words","embeddable":true,"href":"https:\/\/iach2019.cme-congresses.com\/wp-json\/wp\/v2\/yst_prominent_words?post=12109"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}